A short take arguing that metabolic drugs are valid tools and that people who use them shouldn't feel they have to keep it quiet.
Recap by typeshit. Post by @hawkebr on Instagram.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
Brewers face a new problem as more people take GLP-1 drugs, with Fox59 looking at how the shift is hitting beer demand.
The account says researchers still disagree on how to define excess weight and whether obesity counts as a disease.
Loading…